UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Physician pain and discomfort during minimally invasive gynecologic cancer surgery

Gynecologic oncology, 2014-08, Vol.134 (2), p.243-247

2014

Volltextzugriff (PDF)

The SHAPE trial: is good is good enough?

Journal of gynecologic oncology, 2024-07, Vol.35 (4), p.1

R. Wendel Naumann

2024

Volltextzugriff (PDF)

Advances in immunotherapy for cervical cancer

Current opinion in oncology, 2020-09, Vol.32 (5), p.481-487

2020

Volltextzugriff (PDF)

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2825-2834

2019

Volltextzugriff (PDF)

The SHAPE trial: is good is good enough?

Journal of Gynecologic Oncology, 2024, 35(4), , pp.1-4

Naumann, R Wendel

2024

Volltextzugriff (PDF)

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology

International journal of gynecological cancer, 2015-07, Vol.25 (6), p.1121-1127

2015

Volltextzugriff (PDF)

Minimally Invasive Radical Hysterectomy Has Many Benefits Compared with Open Radical Hysterectomy: Will the LACC Trial Cause the Premature Demise of This Procedure?

Journal of minimally invasive gynecology, 2019-03, Vol.26 (3), p.379-380

Naumann, R. Wendel

2019

Volltextzugriff (PDF)

The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage

American journal of obstetrics and gynecology, 2021-10, Vol.225 (4), p.397.e1-397.e6

2021

Volltextzugriff (PDF)

Re-evaluating “Success” as It Pertains to Surgical Trials

Journal of minimally invasive gynecology, 2021-03, Vol.28 (3), p.496-501

Naumann, R. Wendel

2021

Volltextzugriff (PDF)

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?

Gynecologic oncology, 2012-07, Vol.126 (1), p.5-11

Naumann, R. Wendel

2012

Volltextzugriff (PDF)

Ovarian cancer: screening and future directions

International journal of gynecological cancer, 2019-01, Vol.29 (1), p.195-200

2019

Volltextzugriff (PDF)

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

Drugs (New York, N.Y.), 2011-01, Vol.71 (11), p.1397-1412

2011

Volltextzugriff (PDF)

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

The lancet oncology, 2024-05, Vol.25 (5), p.588-602

2024

Volltextzugriff (PDF)

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4400-4406

2013

Volltextzugriff (PDF)

Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?

Gynecologic oncology, 2018-04, Vol.149 (1), p.117-120

2018

Volltextzugriff (PDF)

Phase III trials in ovarian cancer: The evolving landscape of front line therapy

Gynecologic oncology, 2019-05, Vol.153 (2), p.436-444

2019

Volltextzugriff (PDF)

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2811-2818

2007

Volltextzugriff (PDF)

The Benefits of Laparoscopic Radical Hysterectomy for Cervical Cancer: Res Ipsa Loquitur?

Journal of minimally invasive gynecology, 2022-07, Vol.29 (7), p.805-806

2022

Volltextzugriff (PDF)

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Journal of clinical oncology, 2022-08, Vol.40 (23), p.JCO2101801-2577

2022

Volltextzugriff (PDF)

15 years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

Gynecologic oncology, 2017-01

2017

Volltextzugriff (PDF)

Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial

Gynecologic oncology, 2024-06, Vol.185, p.143-147

2024

Volltextzugriff (PDF)

Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey

Journal of minimally invasive gynecology, 2019-07, Vol.26 (5), p.838-846

2019

Volltextzugriff (PDF)

The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals

American journal of obstetrics and gynecology, 2012-09, Vol.207 (3), p.174.e1-174.e7

2012

Volltextzugriff (PDF)

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Gynecologic oncology, 2020-07, Vol.158 (1), p.16-24

2020

Volltextzugriff (PDF)

TP021/#1540 Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A255-A255

2023

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Englisch
(136)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Physician pain and discomfort during minimally invasive gynecologic cancer surgery

The SHAPE trial: is good is good enough?

Advances in immunotherapy for cervical cancer

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

The SHAPE trial: is good is good enough?

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology

Minimally Invasive Radical Hysterectomy Has Many Benefits Compared with Open Radical Hysterectomy: Will the LACC Trial Cause the Premature Demise of This Procedure?

The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage

Re-evaluating “Success” as It Pertains to Surgical Trials

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?

Ovarian cancer: screening and future directions

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?

Phase III trials in ovarian cancer: The evolving landscape of front line therapy

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

The Benefits of Laparoscopic Radical Hysterectomy for Cervical Cancer: Res Ipsa Loquitur?

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

15 years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial

Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey

The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

TP021/#1540 Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha

Suchergebnisse filtern